Home » Lung Cancer Screening Study at UCMC to Utilize Precipio ICE-COLD PCR Tech

Lung Cancer Screening Study at UCMC to Utilize Precipio ICE-COLD PCR Tech

Nov 27, 2018
|
staff reporter

NEW YORK (GenomeWeb) — Precipio said today that the University of Cincinnati Medical Center (UCMC) will use its ICE-COLD PCR (ICP) mutation enrichment technology in a study screening for clinically actionable mutations in non-small cell lung cancer (NSCLC) patients.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Hackers Go After Genome Data

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

What's This Personalized Medicine?

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

No Gene Drive Ban

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

This Week in Science

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Dec
12
Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

What's Popular?

In Molecular Diagnostics

  1. Qiagen to Develop Companion Dx for Novartis Breast Cancer Drug

  2. Grail Launches New Early Cancer Detection Study, Refocuses Strategy to Multi-Cancer Test

    Premium

  3. Cancer Whole-Genome and Transcriptome Test Expands NYGC's Clinical Services

    Premium

  4. New York State Approves OneOme PGx Test

  5. Myriad Genetics Describes Advancement of Hispanic-Specific Breast Cancer Polygenic Risk Score

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.